S Rehan Ahmad, (PhD)

About

S. Rehan Ahmad (Ph.D.) is a distinguished Assistant Professor and Head of the Department of Microbiology at HMMCW, Kolkata, affiliated with West Bengal State University. He is an accomplished researcher, academic editor, and innovator with extensive expertise in microbiology, medicinal chemistry, precision medicine, and neurodegenerative diseases. Dr. Ahmad is a Patentee, Entrepreneur, and Book Editor for Elsevier. He serves as the Vice President of the Institution's Innovation Council (IIC), Ministry of Education (MoE), Government of India, and as an Academic Editor for PLOS ONE. With over 60 published articles, six authored books, and more than 25 patents, he has established himself as a leader in multidisciplinary research. His work spans diverse fields, including drug discovery, environmental biotechnology, neurobiology, and the gut microbiome, with a particular focus on neurodegenerative diseases and their pharmacogenomic and therapeutic advancements. Dr. Ahmad's contributions extend to mentoring doctoral fellows, spearheading research proposals, and promoting innovation in science and education.

Employment

• UCSI University Guest Lecturer (Online / Hybrid Mode)
  2024 - Present
• Hiralal Mazumdar Memorial College for Women , West Bengal State University Assistant Professor
  2019 - Present
• Indira Gandhi National Open University Approved Academic Counselor (Assistant Professor)
  2019 - 2019

Education

• University of California, San Diego Professional Certificate Course
  2024 - 2024
• University of Manchester Professional Certificate Course
  2022 - 2022
• Harvard University Professional Certificate Course
  2022 - 2022
• University of Calcutta B.Ed.
  2004 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (47)

• From Dysbiosis to systemic health: Microbiome modulation as a unified therapeutic framework
  Acta Microbiologica et Immunologica Hungarica 2026 DOI: 10.1556/030.2026.03015
  +Save
• Mitochondrial Dysfunction in Circulating Blood Cells and Biological Aging: A Review of Mechanisms and Evidence
  Biomolecules 2026 DOI: 10.3390/biom16070972
  +Save
• Loss-of-function variant of SLC27A3 causes mitochondrial dysfunction and a metabolic neurodevelopmental disorder via impaired fatty acid transport
  Journal of Human Genetics 2026 DOI: 10.1038/s10038-025-01435-w
  +Save
• Precision-Engineered CD3 T-Cell Engagers for Solid Tumours: Conditional Activation, Microenvironment Modulation, and Clinical Translation
  Cancers 2026 DOI: 10.3390/cancers18071088
  +Save
• Urban–rural disparities in menarcheal timing: a longitudinal cohort study examining social determinants of health (SDOH), screen time, and hormonal influences among adolescent girls in West Bengal, India
  BMC Public Health 2026 DOI: 10.1186/s12889-026-26938-9
  +Save
• Pathogenic DDX39A Variant Disrupts Nuclear Homeostasis and Causes an Early‐Onset Neurodegenerative Disorder With Cerebral Atrophy
  Clinical Genetics 2026 DOI: 10.1111/cge.70033
  +Save
• An Unstable ATG2A Variant Causes a Neurodegenerative Disorder via Impaired Autophagy and Proteotoxic Stress in Brain Atrophy
  Clinical Genetics 2026 DOI: 10.1111/cge.70019
  +Save
• TTC14 dysfunction contributing to microcephaly and lissencephaly spectrum features through protein mislocalization and impaired RNA processing
  Human Genetics 2026 DOI: 10.1007/s00439-026-02862-1
  +Save
• Pathogenic ZNF319 variant disrupts nuclear localization and transcriptional regulation to cause a novel form of autosomal recessive leukodystrophy
  Journal of Human Genetics 2025 DOI: 10.1038/s10038-025-01386-2
  +Save
• Effects of Probiotic Supplementation on Depressive Symptoms, Sleep Quality, and Modulation of Gut Microbiota and Inflammatory Biomarkers: A Randomized Controlled Trial
  Brain Sciences 2025
  +Save